Advanced Biomed Inc. Common Stock
ADVB | NASDAQ
$6.81
+$0.34 (+5.26%)
Sep 22, 2026, 12:48 PM ET · Market open
TTM Period Ending | Q3 2026 Mar 30, 2026 | Q2 2026 Dec 30, 2025 | Q1 2026 Sep 29, 2025 | Q4 2025 Jun 29, 2025 | Q3 2025 Mar 30, 2025 | Q2 2025 Dec 30, 2024 | Q1 2025 Sep 29, 2024 | Q4 2024 Jun 29, 2024 | Q3 2024 Mar 30, 2024 | Q2 2024 Dec 30, 2023 | Q1 2024 Sep 29, 2023 | Q4 2023 Jun 29, 2023 | Q3 2023 Mar 30, 2023 | Q2 2023 Dec 30, 2022 | Q1 2023 Sep 29, 2022 | Q4 2022 Jun 29, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 2.85K | 2.55K | 2.76K | 2.76K | 679.77 | 3.05K | 2.38K | 2.38K | 2.38K | n/a | 2.32K | 2.32K | 6.2K | 6.2K | 3.89K | 3.89K |
Gross Profit | -2.84K | -2.55K | -2.76K | -2.76K | -679.77 | -3.05K | -2.38K | -2.38K | -2.38K | n/a | -2.32K | -2.32K | -6.2K | -6.2K | -3.89K | -3.89K |
Operating Income | -1.1M | -1.34M | -1.33M | -1.33M | -2M | -1.26M | -1.9M | -1.82M | -2.13M | -2.9M | -2.28M | -2.25M | -1.26M | -472.61K | -445.41K | -36.79K |
Interest Income | 1.05K | 1.05K | 1.23K | 793.45 | 33.9K | 34K | 53.49K | 53.5K | 41.36K | 41.24K | 21.5K | 21.93K | 649.08 | 667 | 443 | n/a |
Pretax Income | -672.96K | -1.57M | -1.81M | -1.69M | -2.48M | -1.13M | -1.26M | -1.77M | -2.64M | -3.12M | -2.98M | -3.36M | -1.77M | -1.25M | -1.24M | -91.73K |
Net Income | -677.61K | -1.57M | -1.82M | -1.7M | -2.49M | -1.15M | -1.26M | -1.77M | -2.64M | -3.12M | -2.98M | -3.36M | -1.77M | -1.25M | -1.24M | -91.73K |
Selling & General & Admin | 573.11K | 735.27K | 730.37K | 780.8K | 928.22K | 502.65K | 937.14K | 870.24K | 1.19M | 1.73M | 1.3M | 1.3M | 814.34K | 260.92K | 254.22K | 13.39K |
Research & Development | 492.8K | 500.04K | 500.61K | 446.32K | 647.84K | 405K | 586.82K | 574.3K | 853.36K | 1.05M | 883.71K | 831.13K | 362.47K | 154.3K | 136.12K | 19.52K |
Other Expenses | 27.32K | 100.83K | 100.83K | 100.8K | 419.29K | 372.95K | 399.96K | 399.6K | 113.64K | 115.11K | 112.5K | 136.76K | 233.96K | 205.33K | 180.92K | 129.74K |
Operating Expenses | 1.09M | 1.34M | 1.33M | 1.33M | 2M | 1.25M | 1.9M | 1.82M | 2.13M | 2.9M | 2.27M | 2.24M | 1.26M | 466.4K | 441.52K | 32.9K |
Interest Expense | 112 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 58 | 58 | 58 | 58 |
Selling & Marketing Expenses | 7.22K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.1M | 1.34M | 1.33M | 1.33M | 2M | 1.26M | 1.9M | 1.82M | 2.13M | 2.9M | 2.28M | 2.25M | 1.26M | 472.61K | 445.41K | 36.79K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.28M | 1.08M | 1.08M | 1.08M | 1.02M | 1M | 1.08M | 1M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M |
Shares Outstanding (Diluted) | 1.28M | 1.08M | 1.08M | 1.08M | 1.02M | 1M | 1.08M | 1M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M |
EPS (Basic) | -0.21 | 0.13 | -0.10 | -0.09 | -0.11 | -0.11 | -0.09 | -0.10 | -0.12 | -0.09 | -0.10 | -0.11 | -0.15 | -0.13 | -0.12 | -0.08 |
EPS (Diluted) | -0.21 | 0.13 | -0.10 | -0.09 | -0.11 | -0.11 | -0.09 | -0.10 | -0.12 | -0.09 | -0.10 | -0.11 | -0.15 | -0.13 | -0.12 | -0.08 |
EBITDA | -1M | -1.05M | -1.05M | -991.73K | -1.34M | -851.6K | -1.42M | -1.35M | -1.82M | -2.54M | -1.99M | -1.88M | -1.06M | -301.9K | -277.01K | -32.9K |
EBIT | -1.06M | -1.34M | -1.33M | -1.33M | -2M | -1.28M | -1.92M | -1.84M | -2.15M | -2.9M | -2.28M | -2.25M | -1.26M | -472.61K | -445.41K | -36.79K |
Depreciation & Amortization | 59.87K | 284.51K | 284.73K | 338.95K | 655.36K | 423.77K | 496.45K | 483.54K | 332.04K | 361.02K | 289.98K | 365.17K | 202.08K | 170.71K | 168.4K | 3.89K |
Add to Watchlist
Select watchlists to add or remove ADVB